๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› China
Clinical trial register · China

Studies with a Chinese investigative site

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the register
Recruitment status
Phase
Lead sponsor
Sun Yat-sen University490 Fudan University472 Second Affiliated Hospital, Zhejiang University, School of Medicine404 Peking Union Medical College Hospital282 Ruijin Hospital281
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to
19052 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Pharmacokinetic Study of Sudapyridine๏ผˆWX-081๏ผ‰in Healthy Chinese Subjects
NCT06701110TB
Shanghai Jiatan Pharmatech Co., Ltd
Phase 1
10
Suzhou
2024-09-04
Recruiting
Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
NCT06548542Crohn's Disease
AbbVie
Phase 2
540
2024-09-04
Active, closed
A Study of TAK-279 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT06550076Plaque Psoriasis
Takeda
Phase 3
2,099
Beijing, Chongqing, Fuzhou, Guangzhou, Shijiazhuang, Wuhan, Zhenjiang, Shanghai
2024-09-04
Recruiting
Er:YAG Laser and Air Polishing Application in Periodontal Treatment
NCT06574802Periodontitis
Beijing Chao Yang Hospital
Not applicable
60
Beijing
2024-09-04
Active, closed
Timing of Endoscopy in Cirrhotic Patients With Acute Variceal Bleeding
NCT06031402Acute Upper Gastrointestinal Bleeding, Acute Variceal Bleeding
General Hospital of Shenyang Military Region
Not applicable
368
Shenyang
2024-09-04
Recruiting
Evaluation of the Efficacy and Safety of Furmonertinib Combined with Bevacizumab As First-Line Treatment for EGFR-Positive Non-Small Cell Lung Cancer with Brain Metastases: a Single-Arm, Open-Label, Prospective Phase II Clinical Study
NCT06728865Non-small Cell Lung Cancer (NSCLC), EGFR Mutation-Positive Lung Cancer, Brain Metastases, Leptomeningeal Metastases
Li-kun Chen
Phase 2
70
Guangzhou
2024-09-04
Recruiting
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
NCT06482905High-grade Glioma, WHO Grade โ…ฃ Glioma
Tcelltech Inc.
Phase 1
52
Beijing
2024-09-04
Recruiting
A Study to Assess the Efficacy and Safety of WSD0922-FU in Patients With EGFRm+ Advanced Non-small Cell Lung Cancer
NCT06631989EGFR Mutation Positive Advanced Non-Small Cell Lung Cancer
Wayshine Biopharm, Inc.
Phase 1/2
100
Hefei, Beijing, Guangzhou, Zhengzhou, Jinan, Shanghai, Chengdu, Tianjin
2024-09-04
Recruiting
The EEG Study Under Sevoflurane Anesthesia in Children
NCT06580028Electroencephalography, Sevoflurane, Child Neglect
Second Affiliated Hospital of Wenzhou Medical University
Observational
280
Wenzhou
2024-09-04
Recruiting
Study of AXT-1003 in Subjects With Advanced Malignant Tumors.
NCT06484985Non-Hodgkin Lymphoma, Advanced Solid Tumor
Axter Therapeutics (Beijing) Co., Ltd
Phase 1
78
Beijing, Changsha, Fuzhou, Guangzhou, Shanghai
2024-09-04
Recruiting
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
NCT06289751Cervical Cancer, Neoadjuvant Chemoimmunotherapy, Radical Hysterectomy, Extrafascial Hysterectomy
Tongji Hospital
Phase 2
50
Wuhan, Jinan
2024-09-03
Recruiting
A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients
NCT06493760Metastatic Colorectal Cancer
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Phase 2
130
Shanghai
2024-09-03
Recruiting
A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
NCT06635798Tetanus
Genrix (Shanghai) Biopharmaceutical Co., Ltd.
Phase 3
582
Hefei, Beijing, Guangzhou, Shenzhen, Liuzhou, Zunyi, Wuhan, Hengyang
2024-09-03
Recruiting
Neoadjuvant Adebrelimab Plus Chemotherapy for Esophageal Cancer: A Clinical Study
NCT07437898Esophageal Squamous Cell Carcinoma
The Affiliated Hospital of Putian University
Phase 2
42
Putian
2024-09-03
By invitation
Screening and Prospective Cohort Study of Risk Factors for Enhanced Recovery After Spinal Fusion Surgery in Advanced Age Patient
NCT06591442Lumbar Disk Herniation, Lumbar Spinal Stenosis, Lumbar Spondylolisthesis, Cervical Spondylotic Myelopathy
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Observational
500
Wuhan
2024-09-03
Recruiting
A RWS of SC MTX in Chinese RA Patients
NCT07463937Rheumatoid Arthritis (RA)
Peking University People's Hospital
Observational
10,000
Beijing
2024-09-03
Recruiting
Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
NCT05556460Tricuspid Regurgitation
Hangzhou Valgen Medtech Co., Ltd
Not applicable
236
Chengdu, Hangzhou
2024-09-03
Recruiting
First-in-human Study of DB-1419 for Advanced/Metastatic Solid Tumors
NCT06554795Solid Tumor, Adult
DualityBio Inc.
Phase 1/2
360
Hefei, Beijing, Jilin City, Chongqing, Fuzhou, Nanning, Harbin, Luoyang
2024-09-03
Active, closed
Evaluate the Efficacy and Safety of SASI Compared with RYGB in the Treatment of Obesity and Related Metabolic Diseases
NCT06598267Bariatric Surgery
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Not applicable
304
Nanjing
2024-09-03
Recruiting
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
NCT06512584Short Bowel Syndrome
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 3
72
Beijing, Chongqing, Guangzhou, Changsha, Nanjing, Qingdao, Shanghai, Xiโ€™an
2024-09-03
Recruiting
Oral Fecal Microbiota Transplantation in Advanced Hepatocellular Carcinoma After Progression on ICI-TKI Therapy
NCT06563947Advanced Hepatocellular Carcinoma
Xu Yong, MD
Phase 2
30
Shenzhen
2024-09-03
Recruiting
Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma
NCT07648069Soft Tissue Sarcoma (STS), Osteosarcoma
Sun Yat-sen University
Phase 1
16
Guangzhou
2024-09-03
Recruiting
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
NCT06477536Generalized Pustular Psoriasis
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 2/3
33
Beijing, Hangzhou
2024-09-02
Recruiting
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
NCT06283719Small Cell Lung Cancer, Neuroendocrine Cancer
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Phase 1/2
265
Shanghai
2024-09-02
Recruiting
A Phase I Study on Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics and Preliminary Efficacy of SXRN Plasmid DNA Technique in Patients With Advanced Solid Tumors
NCT06736275Advanced Cancer, Cachexia
Jiangsu Nutai Biologics Co., Ltd
Phase EARLY_PHASE1
28
Beijing
2024-09-02
Recruiting
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NCT06215989Acute Coronary Syndrome, Unstable Angina, ST Elevation Myocardial Infarction, Non ST Segment Elevation Myocardial Infarction
Beijing Anzhen Hospital
Not applicable
6,574
Beijing
2024-09-02
Recruiting
Dexmedetomidine Reduces Sevoflurane MAC-BAR During Pneumoperitoneum
NCT06575179Laparoscopic Cholecystectomy
Fujian Provincial Hospital
Phase 4
90
Fuzhou
2024-09-02
Recruiting
CS-206 in Patients With Sickle Cell Disease
NCT06565026Sickle Cell Disease
CorrectSequence Therapeutics Co., Ltd
Phase EARLY_PHASE1
5
Nanning
2024-09-02
Active, closed
A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease
NCT06480461Parkinson's Disease
Shanghai Vitalgen BioPharma Co., Ltd.
Phase 1/2
39
Shanghai
2024-09-02
Recruiting
Noninvasive Prediction of Portal Hypertension in Cirrhosis Using Sound Touch Viscoelastography
NCT06316869Portal Hypertension, Cirrhosis
First Affiliated Hospital of Wenzhou Medical University
Observational
216
Wenzhou
2024-09-02
Recruiting
Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)
NCT06292585EpiDural Hematoma, Traumatic Brain Injury
Changhai Hospital
Not applicable
194
Shanghai
2024-09-02
Recruiting
Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai
NCT06641856Health Personnel
Ruijin Hospital
Observational
300
Shanghai
2024-09-02
Recruiting
PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer
NCT06549855Endometrial Cancer, Endometrioid Carcinoma, Mismatch Repair Deficiency
Peking University People's Hospital
Not applicable
10
Beijing
2024-09-02
Recruiting
Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy
NCT06579937Behavior Problem
Fujian Provincial Hospital
Phase 4
172
Fuzhou
2024-09-02
Recruiting
Neoantigen-loaded DC Vaccine, PD-1 Inhibitor, and Radiotherapy for Advanced NSCLC Progressed After First-line Treatment
NCT06752057Advanced NSCLC
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
By invitation
A Integrated Study in Pediatric Patients with Cardiomyopathy
NCT06641830Pediatric Cardiomyopathy
West China Second University Hospital
Observational
800
Chengdu
2024-09-01
Recruiting
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
NCT06128252Gastric Cancer
Tang-Du Hospital
Not applicable
96
Wuhan, Nanjing, Shenyang, Xi'an, Chengdu, รœrรผmqi, Chongqing, Shanghai
2024-09-01
Active, closed
Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury
NCT06596798AKI
Qianfoshan Hospital
Observational
1,200
Jinan
2024-09-01
Active, closed
Establishment of a Predictive Model for Immunotherapy Response in Pancreatic Cancer
NCT07271823Pancreatic Cancer Non-resectable
Zhejiang Cancer Hospital
Observational
100
Zhejiang
2024-09-01
Active, closed
Different Amounts of Moxibustion in the Treatment of DPN: A Clinical RCT Study
NCT06330233Diabetic Peripheral Neuropathy, Pain, Moxibustion, Randomized Controlled Trial
Zhejiang Chinese Medical University
Not applicable
90
Hangzhou
2024-09-01
Active, closed
Neoadjuvant Therapy for Locally Advanced Rectal Cancer
NCT06853769Colorectal Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase EARLY_PHASE1
48
Nanjing
2024-09-01
Recruiting
Neoantigen-based Peptide Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NCT06751966Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Recruiting
Neoantigen-loaded DC Vaccine and Conventional Third-line Therapy for CRC Progressed After Second-line Treatment
NCT06751953Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Active, closed
Sequential TACE-SBRT Combined With Targeted Immunotherapy for Patients With Intermediate to Advanced Liver Cancer
NCT07230080HCC - Hepatocellular Carcinoma, SBRT, TACE, Immunotherapy
Nanfang Hospital, Southern Medical University
Observational
17
Guangzhou
2024-09-01
Recruiting
Automated Bone Age Estimation From Noncontrast Abdominal CT Using Deep Learning
NCT07162168Bone Aging, Osteoporosis Diagnosis
Peking University People's Hospital
Observational
3,000
Beijing
2024-09-01
Recruiting
Effect of Electronic Moxibustion Apparatus on Pain Degree and Wound Healing of Patients After Craniocerebral Surgery
NCT06534710Patients Undergoing Craniocerebral Surgery
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Not applicable
228
Yiwu
2024-09-01
Active, closed
Research on the Risk Warning Model and Prevention Strategies for Acute Kidney Injury Associated With Cyclosporine Based on Explainable Deep Neural Networks and Therapeutic Drug Monitoring
NCT06596811AKI, Therapeutic Drug Monitoring (TDM)
Qianfoshan Hospital
Observational
1,200
Jinan
2024-09-01
Recruiting
Continuous Effect Of Rehabilitation Training On Pulmonary Arterial Hypertension Patients
NCT07149935Pulmonary Hypertension
RenJi Hospital
Not applicable
104
Shanghai
2024-09-01
Recruiting
Neoadjuvant HAIC and PD-1 Plus Adjuvant PD-1 for High-risk Recurrent HCC
NCT06467799Hepatocellular Carcinoma, Beyond Milan Criteria
Sun Yat-sen University
Phase 2
39
Guangzhou
2024-09-01
Recruiting
Thymalfasin and Recombinant Human IL-2 Injections in Treating Lymphocytopenia for Patients With Malignant Hematological Tumors
NCT06584006Hematological Malignancy, Lymphocytopenia
The First Affiliated Hospital of Xiamen University
Phase 2
50
Xiamen
2024-09-01
Not yet open
Chidamide+Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.
NCT06563778Ineligible Or Refused Transplant Patients With Classical Hodgkin Lymphoma
Chinese PLA General Hospital
Phase 2
100
Beijing
2024-09-01
Recruiting
the Effect of Nutrition-optimized Prehabilitation on Perioperative Intervention in Primary Liver Carcinoma
NCT06549829Hepatocellular Carcinoma, Liver Carcinoma, Hepatobiliary Cancers
Second Affiliated Hospital, Zhejiang University, School of Medicine
Not applicable
120
Hangzhou
2024-09-01
Recruiting
Transthoracic vs Transbronchial Cryoablation for Early-stage Peripheral Lung Cancer
NCT06572540Lung Cancer
Jiayuan Sun
Not applicable
110
Guangzhou, Zhengzhou, Shanghai, Chengdu, Hangzhou
2024-09-01
Recruiting
Magnetic Seizure Therapy for Psychotic Disorders
NCT06581302Psychotic Disorders
Shanghai Jiao Tong University School of Medicine
Not applicable
50
Shanghai
2024-09-01
Active, closed
Diet Intervention on Obesity Related Complication
NCT06719466Obese, Stomach Diseases
Zhang Manna
Not applicable
30
Shanghai
2024-09-01
By invitation
Establishment of Reproductive Cohort and Prediction Model of Genetic Counseling for Mitochondrial Genetic Diseases
NCT06450964Mitochondrial Diseases
Anhui Medical University
Observational
600
Hefei
2024-09-01
Active, closed
A Clinical Trial of Vascular Interventional Robotic System for Cerebral Angiography
NCT07182188Crerbral Angiography
Peking Union Medical College Hospital
Not applicable
660
Beijing
2024-09-01
Recruiting
Hydroxychloroquine in Children's Interstitial Lung Diseases With Genetic Causes
NCT04532346Interstitial Lung Disease, Surfactant Dysfunction
Children's Hospital of Fudan University
Phase EARLY_PHASE1
60
Shanghai
2024-09-01
Recruiting
A Study of the Effect of Real-time Pressure Controllers on Subjective and Objective Symptoms of Peripheral Neuropathy Induced by Albumin Paclitaxel
NCT07019233Real Time Pressure Controller, Breast Cancer, Albumin Paclitaxel, Peripheral Neuropathy
Tianjin Medical University Cancer Institute and Hospital
Not applicable
118
Tianjin
2024-09-01
Not yet open
Phase 1 Trial of KH801
NCT06364501Advanced Solid Tumors
Beijing Kanghong Biopharmaceutical Co., Ltd.
Phase 1
17
Beijing, Guangzhou, Jinan, Chengdu
2024-09-01
Active, closed
Milk Temperature Control and Necrotizing Enterocolitis Risk in Extremely Preterm Infants
NCT06908239Necrotizing Enterocolitis, Preterm
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
Not applicable
250
Chongqing
2024-09-01
Recruiting
Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI
NCT07045532COPD, Lung Cancers
Shanghai Chest Hospital
Observational
100
Shanghai
2024-09-01
Recruiting
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy
NCT07551037Acute Myeloid Leukemia, Personalized Active Immunotherapy, Maintenance Therapy
Fujian Medical University Union Hospital
Phase 1
90
Fuzhou
2024-09-01
Recruiting
Vorolanib in the Second-line Treatment of Patients With Unresectable or Metastatic Renal Cell Carcinoma
NCT06676527Neoplasms, Kidney Neoplasms, Urologic Neoplasms, Urogenital Neoplasms
Jinling Hospital, China
Observational
39
Nanjing
2024-09-01
Recruiting
First Line Sintilimab Combined With Anlotinib and Platinum Doublet Chemotherapy in Malignant Pleural Mesothelioma
NCT05188859Mesothelioma, Malignant, Mesothelioma, Malignant Pleural, Mesothelioma Malignant Advanced
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Phase 2
29
Taiyuan, Beijing
2024-09-01
Recruiting
OSAHS Screening in Diverse Populations
NCT07736872Obstructive Sleep Apnea (OSA), Snoring, Prevalence, Questionnaires and Surveys
Kang Wu
Observational
100,000
Guangzhou, Anshun
2024-09-01
Recruiting
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
NCT07044921Colorectal Cancer Metastatic
Chinese PLA General Hospital
Phase 2
30
Beijing
2024-09-01
Active, closed
Exploring the Expression Level of Cadherin 6 Protein (CDH6) in Primary Malignant Bone Tumor Specimens and Its Clinical Application in Prognosis Assessment
NCT06850506Sarcoma, Sarcoma, Bone, Ewing Sarcoma, Osteosarcoma
Peking University People's Hospital
Observational
70
Beijing
2024-09-01
Recruiting
Doppler Ultrasound-Guided Angiopuncture for Dysmenorrhea Pain: A Clinical Trial
NCT07176910Angiopuncture, Dysmenorrhea, Dopplar Ultrasound
City University of Hong Kong
Not applicable
30
Changchun
2024-09-01
Recruiting
Neural Mechanisms and Clinical Applications of DBS for Modulating Sleep Dysregulation in PD
NCT06914466Deep Brain Stimulation, Parkinson's Disease and Parkinsonism, Sleep Disorder
Xuanwu Hospital, Beijing
Observational
20
Beijing
2024-09-01
Recruiting
Anesthesia Induction Scheme for Painless Gastrointestinal Endoscopy Patients Based on Nociceptive Stimulation Monitoring
NCT06604156Depth of Anesthesia, Nociception, Painless Gastrointestinal Endoscopy
Min Su
Observational
220
Chongqing
2024-09-01
Recruiting
Effects of Neoadjuvant Therapy With Carboplatin, Paclitaxel Combined With Anti-PD-1 Drugs on Pain, Anxiety and Depression in Patients With Resectable Head and Neck Squamous Cell Carcinoma
NCT06575322Head and Neck Squamous Cell Carcinoma
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Observational
302
Guanzhou
2024-09-01
Recruiting
Chemotherapy Combined with Immunotherapy and Targeted Therapy in Cholangiocarcinoma
NCT06718257Cholangiocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
300
Hangzhou
2024-09-01
Not yet open
Hema-NeoTIL01 Cell Infusion Therapy in Relapsed/Refractory Acute Leukemia
NCT06559644Leukemia, Myeloid, Acute, B-cell Acute Lymphoblastic Leukemia
The First Affiliated Hospital of Soochow University
Phase EARLY_PHASE1
20
Suzhou
2024-09-01
By invitation
A Study of the Efficacy and Safety of Non-ablative Fractional Laser in the Treatment of Thyroidectomy Scars
NCT07037264Scars After Surgical Intervention
Chinese Medical Association
Not applicable
120
Beijing
2024-09-01
Recruiting
AI App for Management of Atopic Dermatitis
NCT06362629Atopic Dermatitis, Artificial Intelligence
West China Hospital
Not applicable
232
Chengdu
2024-09-01
By invitation
A Study to Evaluate the Safety and Efficacy of HB0052 in Patients With Advanced Solid Tumors
NCT06992687Solid Tumors
Shanghai Huaota Biopharmaceutical Co., Ltd.
Phase 1/2
30
Beijing
2024-09-01
Recruiting
Tumor-Targeted-NIR-II Fluorescent Molecular Probes for the Identification of Breast Cancer Tissue and SLN Metastatic Status
NCT06713161Breast Cancer, Sentinel Lymph Node, Metastases, Margin Assessment
Yunnan Cancer Hospital
Observational
40
Kunming
2024-09-01
Not yet open
Artificial Intelligence Empowered Anesthesia Ultrasound Guided Regional Anesthesia Training
NCT06546904Ultrasound-guided Regional Anesthesia
Tongji Hospital
Not applicable
40
Wuhan
2024-09-01
Not yet open
Fluzoparib Combined With Dalpiciclib for Platinum Resistant Recurrent Ovarian Cancer
NCT06552858Ovarian Cancer
Fudan University
Phase 2
30
Shanghai
2024-09-01
Recruiting
Application of Early Bundle Management of Mechanical Ventilation to Prevent Ventilator Dependence in Children
NCT06125210Prolonged Mechanical Ventilation
Children's Hospital of Fudan University
Not applicable
150
Shanghai
2024-09-01
Recruiting
Methotrexate Combined With Tofacitinib in Rheumatoid Arthritis
NCT06301373Rheumatoid Arthritis
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Not applicable
130
Foshan, Guangzhou, Jieyang, Shantou
2024-09-01
Recruiting
Association Between Blood Pressure and Risk of PSCI
NCT06730711Stroke, Cognitive Decline, Blood Pressure
First Affiliated Hospital of Chongqing Medical University
Observational
600
Chongqing
2024-09-01
Active, closed
Dalpicilib-Enhanced Vs. Standard Endocrine Therapy in ER+ HER2- Early Breast Cancer
NCT06637150Breast Cancer
Fudan University
Phase 3
1,388
Shanghai
2024-09-01
Recruiting
Deep Learning for Automated Discrimination Between Stage T1-T2 and T3 Renal Cell Carcinoma on Contrast-Enhanced CT
NCT07166445Carcinoma, Renal Cell, Diagnostic Imaging, Pathology, Deep Learning
Peking University First Hospital
Observational
1,000
Beijing
2024-09-01
Not yet open
Ultra-early STatin in Patients With Aneurysmal subaRachnoid Hemorrhage (Ue-STAR)
NCT06559072Subarachnoid Hemorrhage, Subarachnoid Hemorrhage, Aneurysmal, Aneurysmal Subarachnoid Hemorrhage, Hemorrhage, Aneurysmal Subarachnoid
The George Institute
Phase 3
522
Tianjin
2024-09-01
Recruiting
Safety and Efficacy of Cryoablation With Karelizumab and Apatinib for Multiple Lung Cancers
NCT06607770Lung Cancer
Zhou Chengzhi
Phase 1/2
20
Guangzhou
2024-09-01
Recruiting
Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study
NCT07047560Colorectal Cancer (CRC)
Tianjin Medical University Cancer Institute and Hospital
Phase 2
46
Tianjin
2024-09-01
Recruiting
Neoantigen-loaded DC Vaccine and Conventional Second-line Therapy for CRC Progressed After First-line Treatment
NCT06751940Colorectal Cancer (CRC)
The First Affiliated Hospital of Nanchang University
Not applicable
10
Nanchang
2024-09-01
Not yet open
Research on Key Technologies for Risk Prediction and Precise Diagnosis and Treatment of AIS Based on Epigene-phenotype
NCT06506227Adolescent Idiopathic Scoliosis
The First Affiliated Hospital of Zhejiang Chinese Medical University
Not applicable
2,000
Hangzhou
2024-09-01
Recruiting
Hypofractionated Online Adaptive Radiotherapy of Breast Cancer
NCT06568705Breast Cancer
Peking Union Medical College Hospital
Phase 2
40
Beijing
2024-09-01
Recruiting
Energy CT in Imaging and Diagnosis of Gastric Cancer
NCT06869694Gastric Cancer, CT
The First Affiliated Hospital of Zhengzhou University
Observational
300
Zhengzhou
2024-09-01
Recruiting
Disitamab Vedotin Plus Trastuzumab in Patients With HER2 Positive GC/GEJ Patiens
NCT06572319HER2-positive Gastric Cancer, HER2-positive Gastroesophageal Junction Adenocarcinoma
Zhejiang Cancer Hospital
Phase 1/2
35
Hangzhou
2024-09-01
Not yet open
Cryoablation with or Without Serplulimab in Treating Patients with Stage I-IIA Non-small Cell Lung Cancer
NCT06580665Non-small Cell Lung Cancer
Shanghai Chest Hospital
Not applicable
134
Wuhan, Nanchang, Shanghai, รœrรผmqi, Wenzhou
2024-09-01
Recruiting
Fasting Effects on Metabolism and Immunity Study in Human
NCT06779201Fasting
Xuanwu Hospital, Beijing
Not applicable
30
Beijing
2024-09-01
Active, closed
MRI Assessment of Pancreatic Fat Changes and Islet Function Recovery After Bariatric Surgery in Obese Patients
NCT07464223Obesity & Overweight, Type 2 Diabetes Mellitus (T2DM), Pancreatic Steatosis, Insulin Resistance
yu li๏ผŒMD
Observational
50
Qingdao
2024-09-01
Recruiting
Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression
NCT06560528Gastric Cancer, Gastroesophageal Junction Adenocarcinoma
Tianjin Medical University Cancer Institute and Hospital
Phase 2
40
Tianjin
2024-09-01
Recruiting
"Selinexor+Pegaspargase+Dexamethasone"in โ… /โ…ก NKTCL
NCT06559553NKTCL, Selinexor
Mingzhi Zhang
Phase 1/2
50
Zhengzhou
2024-09-01
Recruiting
Plasma Sphingolipid Metabolites and Radiotherapy Efficacy in Hepatocellular Carcinoma
NCT06864221Hepatocellular Carcinoma, Radiotherapy, Treatment Outcome, Biomarkers
Nanfang Hospital, Southern Medical University
Observational
260
Guangzhou
2024-09-01
Recruiting
Irinotecan Hydrochloride Liposome Injection (โ…ก) Combined with Fluorouracil, Folinic Acid, Vermofenib and Cetuximab in First-line Treatment of BRAFV600E Mutated Advanced Colorectal Cancer
NCT06603376Colorectal Carcinoma
Shanghai Changzheng Hospital
Phase 2
75
Shanghai
2024-09-01
Rows per page Showing 11601–11700 of 19052
Previous 115 116 117 118 119 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-china?page=117

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →
→

Browse trials by condition

Breast Cancer (416) Advanced Solid Tumors (183) Gastric Cancer (183) Colorectal Cancer (179) Hepatocellular Carcinoma (161) Advanced Solid Tumor (159) Solid Tumor (145) Non-Small Cell Lung Cancer (144) Acute Ischemic Stroke (138) Lung Cancer (134) Pancreatic Cancer (132) Non-small Cell Lung Cancer (131) Multiple Myeloma (126) Coronary Artery Disease (111) Prostate Cancer (111)
→

Browse trials by site location

Beijing (5484) Shanghai (3827) Guangzhou (3318) Hangzhou (1812) Wuhan (1343) Chengdu (1291) Nanjing (1193) Changsha (1154) Chongqing (1056) Fuzhou (1018) Tianjin (940) Zhengzhou (921) Hefei (875) Jinan (785) Changchun (641)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.